Related Experiment Video

Updated: Aug 4, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Intravenous streptomycin: a useful route of administration

J T Morris1, R H Cooper

  • 1Department of Medicine, Madigan Army Medical Center, Tacoma, Washington.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 1, 1994
PubMed

Insights

Intravenous streptomycin can effectively treat difficult Enterococcus faecalis endocarditis, especially when gentamicin resistance is present. This study suggests considering IV streptomycin as a viable alternative administration route for specific infections.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Cardiology

Background:

  • Streptomycin, an aminoglycoside antibiotic, is primarily administered via intramuscular injection for various infections.
  • Intravenous administration of streptomycin is infrequently reported in medical literature.
  • High-level gentamicin resistance in Enterococcus faecalis poses a therapeutic challenge in treating endocarditis.

Observation:

  • This case report details the successful treatment of endocarditis caused by a gentamicin-resistant Enterococcus faecalis strain.
  • Intravenous streptomycin was utilized as the therapeutic agent in this challenging clinical scenario.
  • The patient's endocarditis was effectively managed using the intravenous streptomycin regimen.

Findings:

  • Intravenous administration of streptomycin proved effective in treating endocarditis caused by a gentamicin-resistant Enterococcus faecalis.
  • The study highlights a successful clinical outcome using an alternative administration route for streptomycin.
  • This approach offers a potential solution for infections where standard treatments are compromised by antibiotic resistance.

Implications:

  • Physicians should consider intravenous streptomycin as a potential alternative route for specific infections, particularly endocarditis.
  • This finding expands the therapeutic options for managing infections caused by multidrug-resistant organisms.
  • Further research into the efficacy and safety of intravenous streptomycin in diverse clinical settings is warranted.

More Related Videos

Manual Restraint and Common Compound Administration Routes in Mice and Rats14:10

Manual Restraint and Common Compound Administration Routes in Mice and Rats

Published on: September 26, 2012

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü602809:08

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028

Published on: January 13, 2017

Related Concept Videos

Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Routes of Drug Administration: Overview01:22

Routes of Drug Administration: Overview

Drug administration involves delivering drugs to the body through various routes, such as enteral, parenteral, and topical.
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...